Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis

Heart

Volumn 96, Issue 14, 2010, Pages 1102-1106

  Gotzmann, Michael ^a   Hehen, Tobias ^a   Germing, Alfried ^a   Lindstaedt, Michael ^a   Yazar, Aydan ^a   Laczkovics, Axel ^a   Mumme, Achim ^b   Mügge, Andreas ^a   Bojara, Waldemar ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; ECHOCARDIOGRAPHY; FEMALE; FEMORAL ARTERY; FUNCTIONAL STATUS; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HORMONAL REGULATION; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SUBCLAVIAN ARTERY; WALKING;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; EPIDEMIOLOGIC METHODS; EXERCISE TEST; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; QUALITY OF LIFE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; WALKING;

EID: 77954444657     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.180661     Document Type: Article

References (24)

1. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
2. Otto CM, Bonow RO. Aortic stenosis. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's heart disease. 8th edn. Philadelphia: WB Saunders, 2008, pp. 1626-8.
3. Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-90.
4. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 2006;47:2141-51.
5. Lung B, Gohlke-Bärwolf C, Tornos P, et al. Working Group on Valvular Heart Disease. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 2002;23:1252-66.
6. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703.
7. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63.
8. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current thirdgeneration self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
9. Rector RS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure, II: content, reliability, and validity of a new measure. Heart Fail 1987;3:198-209.
10. Guyatt GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993;22:185A-191A.
11. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-17.
12. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007;49:1733-9.
13. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-23.
14. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009;53:1829-36.
15. Lang RM, Bierig M, Devereux RB, et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
16. Bojara W, Mumme A, Gerckens U, et al. Implantation of the CoreValve self-expanding valve prosthesis via a subclavian artery approach: a case report. Clin Res Cardiol 2009;98:201-4.
17. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
18. Demers C, McKelvie RS, Negassa A, et al; RESOLVD Pilot Study Investigators. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 2001;142:698-703.
19. Olsson LG, Swedberg K, Clark AL, et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-93.
20. Cohn LH. The long-term results of aortic valve replacement. Chest 1984;85:387-96.
21. Ussia GP, Mulè M, Barbanti M, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009;30:1790-6.
22. Sinha AM, Breithardt OA, Schmid M, et al. Brain natriuretic peptide release in cardiac surgery patients. Thorac Cardiovasc Surg 2005;53:138-43.
23. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-8. (Pubitemid 38678520)
24. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005;26:1023-30. (Pubitemid 40695033)